Economic potential for clinically significant in vitro diagnostics
Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology, 2009.
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | eng |
| Published: |
Massachusetts Institute of Technology
2010
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/1721.1/54672 |
| _version_ | 1811084103859044352 |
|---|---|
| author | Bignami, Adrian (Adrian A.) |
| author2 | Ernst Berndt and Mark Trusheim. |
| author_facet | Ernst Berndt and Mark Trusheim. Bignami, Adrian (Adrian A.) |
| author_sort | Bignami, Adrian (Adrian A.) |
| collection | MIT |
| description | Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology, 2009. |
| first_indexed | 2024-09-23T12:44:52Z |
| format | Thesis |
| id | mit-1721.1/54672 |
| institution | Massachusetts Institute of Technology |
| language | eng |
| last_indexed | 2024-09-23T12:44:52Z |
| publishDate | 2010 |
| publisher | Massachusetts Institute of Technology |
| record_format | dspace |
| spelling | mit-1721.1/546722019-04-12T23:38:36Z Economic potential for clinically significant in vitro diagnostics Bignami, Adrian (Adrian A.) Ernst Berndt and Mark Trusheim. Harvard University--MIT Division of Health Sciences and Technology. Harvard University--MIT Division of Health Sciences and Technology. Harvard University--MIT Division of Health Sciences and Technology. Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology, 2009. Cataloged from PDF version of thesis. Includes bibliographical references (p. 53-56). In recent years, significant advances have been made in the realm of in vitro diagnostics with the development of novel tests which are able to meaningfully impact the course of a patients' disease management. This transformation has strained the traditional in vitro diagnostic business model and raised questions as to whether the economics support the commercial development of these tests. The goal of this study is to evaluate the economics of in vitro diagnostics from development to commercialization, with a focus on a specific a class of novel and complex tests called In Vitro Diagnostic Multivariate Index Assays (IVDMIA). My hypothesis is that the current dynamics of the market can only sustain a small number of such novel tests. To evaluate this hypothesis, I construct an economic model of the development of a hypothetical new in vitro diagnostics which focuses on both the cost of development and commercialization together with market potential and adoption. The analysis reviews specific break-even scenarios to determine the parameters which would allow for an economically viable complex in vitro diagnostic. The conclusion I reach based on this analysis is that only a very small number of medical conditions could economically support the development of a novel in vitro diagnostic. The medical conditions which could support the development of a novel test are governed by complexity, severity and prevalence of the disease. Given the dramatic impact these new tests may have on disease management, incentives may be required to offset the risks associated with expanding novel diagnostics into smaller but medically significant disease areas. by Adrian A. Bignami. S.M. 2010-04-28T17:18:07Z 2010-04-28T17:18:07Z 2009 2009 Thesis http://hdl.handle.net/1721.1/54672 607346985 eng M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission. http://dspace.mit.edu/handle/1721.1/7582 56 p. application/pdf Massachusetts Institute of Technology |
| spellingShingle | Harvard University--MIT Division of Health Sciences and Technology. Bignami, Adrian (Adrian A.) Economic potential for clinically significant in vitro diagnostics |
| title | Economic potential for clinically significant in vitro diagnostics |
| title_full | Economic potential for clinically significant in vitro diagnostics |
| title_fullStr | Economic potential for clinically significant in vitro diagnostics |
| title_full_unstemmed | Economic potential for clinically significant in vitro diagnostics |
| title_short | Economic potential for clinically significant in vitro diagnostics |
| title_sort | economic potential for clinically significant in vitro diagnostics |
| topic | Harvard University--MIT Division of Health Sciences and Technology. |
| url | http://hdl.handle.net/1721.1/54672 |
| work_keys_str_mv | AT bignamiadrianadriana economicpotentialforclinicallysignificantinvitrodiagnostics |